36th Cycle
ALQUATI CHIARA (Sup. Prof. Luigi Ricciardiello) - Prevention of colorectal cancer characterized by alterations of WNT and mTOR signals through the use of bioactive substances: effect on organoids and colorectal cancer lines
ALTAVILLA AMELIA (Sup. Dr. Ugo De Giorgi) - Prognostic role of PSMA PET in metastatic prostate cancer
ARPA DONATELLA (Sup. Dr. Anna Tesei) - Accelerated Hypofractionated intensity – modulated radiotherapy after hyperbaric oxygenation for recurrent high grade glioma: a pilot study
ASGHAR SIDRA (Sup. Prof. Lorenzo Montanaro) - Identification and Evaluation of snoRNA levels in HCC: A Study explaining the role Played by snoRNA in HCC development
BUGIARDINI RAFFAELE (Sup. Prof. Andrea Pession) - Monitoring of anthracycline cardiotoxicity by tissue Doppler in patients with oncological diseases
CORTESI ANNALISA (Sup. Dr. Luca Frassineti) - Impact of radiotherapy treatment methods in non-metastatic prostate cancer: development and analysis of a large data-base
DE GIGLIO ANDREA (Sup. Prof. Andrea Ardizzoni) - Predictive factors of response to targeted therapies and immunotherapy in lung cancer
DURANTE GIORGIO (Sup. Prof.ssa Manuela Ferracin) - Liquid biopsy approaches in cancer management
FAUSTI VALENTINA (Sup. Dr. Toni Ibrahim) - Evaluation of prognostic, predictive and therapeutical role of immune infiltrating cells in soft tissue and bone sarcomas
FORMENTINI LAURA (Sup. Prof.ssa Katia Scotlandi) - Genetic/molecular characterization of primary bone sarcomas
GELSOMINO FRANCESCO (Sup. Prof. Andrea Ardizzoni) - Understanding molecular mechanisms of resistance to immune check-point inhibitors in advanced non-small cell lung cancer (NSCLC)
GHIGI GIULIA (Sup. Dr.ssa Anna Tesei) - Radiomic and radiogenomic analysis in glioblastoma multiforme: implications for personalization of radiotherapy treatment
LOLLI CRISTIAN (Sup. Dr. Ugo De Giorgi) - Combining molecular alterations and functional imaging in metastatic castration resistant prostate cancer
MARCONI GIOVANNI (Sup. Prof. Michele Cavo) - New prognostic approaches and therapeutic strategies in acute myeloid leukemia in elderly patients
MOLLICA VERONICA (Sup. Prof. Andrea Ardizzoni) - PET/CT imaging for evaluating early response and genetic alterations associated with resistance to novel androgen receptor targeted agents in castration resistant prostate cancer patients
MONALDI CECILIA (Sup. Prof.ssa Simona Soverini) - Resetting SetD2/H3K36ME3 deficiency in advanced systemic mastocytosis
NANNI LAURA (Sup. Prof. Pier Luigi Zinzani) - Efficacy and safety study of CAR-T cell therapy in relapsed and refractory lymphomas: current indications and future prospects
PALLESCHI MICHELA (Sup. Dr. Ugo De Giorgi) - Germline variants in genes other than BRCA1/2 in high-risk patients: potential impact on breast cancer predisposition
PETROCELLI GIOVANNA MARIA (Sup. Prof.ssa Silvia Canaider) - Search for new strategies in regenerative medicine
PROCHOWSKI IAMURRI ANDREA (Sup. Dr. Domenico Barone) - Radiomic features predicting response to chemotherapy in pancreatic cancer
RICCI COSTANTINO (Sup. Prof. Michelangelo Fiorentino) - Integration of histological, immunohistochemical and molecular biology techniques with clinical-dermatoscopic data in the diagnosis of skin tumors
RIEFOLO MATTIA (Sup. Prof.ssa Antonietta D’Errico) - Cancers of Unknown Primary site (CUPs) as a model of metastatic process
ROMEO ANTONINO (Sup. Dr. Ugo De Giorgi) - Twice High dose external beam Radiotherapy by Image-guided tomotherapy for organ-confined Prostate cancer treatment emulating HDR brachytherapy
SCALAMBRA LAURA (Sup. Prof. Pier-Luigi Lollini) - Target genes in HER2 discordant preclinical mammary carcinoma models
SHANKAR VARUN (Sup. Prof. Giovanni Brandi) - Immunological properties of transfer factor in cancer immunotherapies and vaccines: a pre-clinical investigation
SOLLI VINCENZA (Sup. Prof.ssa Elena Zamagni) - Integrative study on Multiple Myeloma: Development of a “Machine Learning” algorithm to identify disease biomarkers predictive of the clinical course of the disease
SPAZZOLI BENEDETTA (Sup. Prof. Davide Maria Donati) - How to predict treatment response and prognosis in Ewing sarcoma: identification of exoxomial and blood circulating biomarkers
TONTINI LUCA (Sup. Prof. Marco Maltoni) - Evaluation of toxicity of healthy tissues subjected to radio-immunotherapy in metastatic cancer patients
TORACCHIO LISA (Sup. Prof.ssa Katia Scotlandi ) - Characterization of the molecular mechanisms mediated by the insulin-like growth factor-2 mRNA binding proteins family in CIC-DUX4 sarcoma malignancy
VENNARINI SABINA (Sup. Dr. Maurizio Amichetti) - Retrospective study and development of a prospective management in patients with breast cancer with local-regional recurrence after irradiated and non-irradiated mastectomy
ZAMAGNI ALICE (Sup. Prof. A. G. Morganti) - Preoperative radiotherapy associated with neoadjuvant systemic treatment in breast cancer
35th Cycle
ANTONAROS FRANCESCA (Sup. Prof. Pier-Luigi Lollini) - Correlation between genotype and phenotype in trisomy 21
AUTERI GIUSEPPE (Sup. Prof. Michele Cavo) - Polycythemia Vera: Creation of a clinical registry for real-world analysis and discovery of liquid biopsy assays to identify biomarkers related to thrombotic risk
BATTISTI SOFIA (Sup. Prof.ssa Emanuela Giampalma) - Clinical application of texture analysis in cancer patient
CANALE MATTEO (Sup. Dr.ssa Paola Ulivi) - Targeting epigenetic mechanisms in gastric cancer
COMITO FRANCESCA (Sup. Prof. Andrea Ardizzoni) - Prospective Study of Therapy Resistance Mechanisms in Advanced Melanoma
DALL'OLIO FILIPPO GUSTAVO (Sup. Prof. Andrea Ardizzoni) - Predictive factor of benefit, response evaluation and mechanism of resistance to Immune Checkpoint Inhibitors (ICI) in Non Small Cell Lung Cancer (NSCLC)
DI NUNNO VINCENZO (Sup. Andrea Ardizzoni) - PET/CT imaging for evaluating early response to novel androgen receptor targeted agents in castration resistant prostate cancer patients
DIONISI FRANCESCO (Sup. Prof. Alessio G. Morganti) - Treatment of primary liver tumors with proton therapy: development and activation of an experimental treatment protocol
FABBRI VISCARDO PAOLO (Sup. Prof.ssa Maria Pia Foschini) - Molecular characterization of central nervous system neoplasms: the new frontiers of genetics and epigenetics
FAROLFI ALBERTO (Sup. Dr. Ugo De Giorgi) - Identification of biomarkers in ovarian cancer (treated with HIPEC)
GURRIERI LORENA (Sup. Dr. Toni Ibrahim) - Clinical and biological role of adjuvant Dendritic Cells Vaccination in newly and recurrence glioblastoma patients combined with immunocheckpoint therapy
LAMBERTI GIUSEPPE (Sup. Prof. Andrea Ardizzoni) - A phase II, single arm study of CarbopLatin plus Etoposide with Bevacizumab and Atezolizumab in patients with exTEnded-disease small-cell lung cancer (SCLC) – CeLEBrATE trial
MATTEUCCI LAURA (Sup. Dr. Luca Frassineti) - Testing Olaparib in combination with Temozolamide in patients with chemorefractory metastatic colorectal cancer and MGMT promoter methylation
MAZZESCHI MARTINA (Sup. Prof. Yosef Yarden) - Cancer omics strategies for personalized treatments
MILAZZO MADDALENA (Sup. Prof. Stefano Salvioli) - Aging and neurodegeneration: identification of biological age markers in patients with Parkinson's or Alzheimer's disease
MONTI MANLIO (Sup. Dr. Luca Frassineti) - Predictive indicators of compliance and response to neoadjuvant/perioperative chemotherapy in operable gastric cancer
MORIGI ALICE (Sup. Prof. Pier Luigi Zinzani) - Role of the combination of Obinutuzumab and Idelalisib in the treatment of relapsed and refractory follicular lymphomas: a phase II pilot study
RAPPOSELLI ILARIO GIOVANNI (Sup. Dr. Luca Frassineti) - Identification of predictive factors in advanced pancreatic cancer by means of extracellular vesicle analysis
RICCI MARIANNA (Sup. Prof. Marco Maltoni) - Evaluation of predictive biomarkers of cachexia in Diffuse Large B Cell Lymphoma (DLBCL) - a Pilot Study
RICCIUTI BIAGIO (Sup. Prof. Andrea Ardizzoni) - Understanding molecular mechanisms of resistance to immune check-point inhibitors in advanced non-small cell lung cancer (NSCLC)
RIZZELLO ILARIA (Sup. Prof. Michele Cavo) - Identification of new strategies for the assessment of minimal residual disease in multiple myeloma: liquid biopsy
RUZZI FRANCESCA (Sup. Prof. Pier -Luigi Lollini) - Study of genes involved in the progression of HER2 positive breast cancer for the identification of new therapeutic targets
SCARPONE MARIA (Sup. Prof.ssa Olivia Manfrini) - Cardiotoxic Effects of Antineoplastic Agents: Risk Stratification and Management of Breast Cancer Patient
SGARZI MICHELA (Sup. Prof. Andrea Ardizzoni) - Modulation of EGFR signalling by cross -talk with other membrane receptor pathways
TADDIA ALBERTO (Sup. Prof. Andrea Pession) - Development of cellular models for the study of clear cell sarcomas in the pediatric kidney
VALGIUSTI MARTINA (Sup. Dr. Luca Frassineti) - Evaluation of potential predictive markers of treatment response and/or prognostic factors by miRNA assessment in patients with locally advanced esophageal cancer undergoing integrated trimodality treatment
VARRONE ELISA (Sup. Prof. Maurizio Brigotti) - Role of Shiga toxins in the pathogenesis of hemolytic uremic syndrome
34th Cycle
BERTUZZI CLARA (Sup. Prof. Andrea Pession) - Definition of the pathogenetic role of microenvironment in Follicular Lymphoma
BONGIOVANNI ALBERTO (Sup. Prof. Andrea Ardizzoni) - Predictive and progonostic role of biological markers in Neuroendocrine Neoplasia and evaluation activity and safety of second line treatments in Neuroendocrine Carcinoma patients
BRIGHI NICOLE (Sup. Prof. Davide Campana) - The role of MGMT promoter methylation as predictive factor for temozolomidebased treatment in neuroendocrine neoplasms: a prospective, observational study
BROSEGHINI ELISABETTA (Sup. Prof. Lorenzo Montanaro) - Role of non-coding RNA alterations in melanoma
CALAFATO GIULIA (Sup. Prof. Andrea Bolognesi) - Isolation, characterization and possible clinical applications of plant rRNA N glycosylases
CALDONI GIULIA (Sup. Prof.ssa Katia Scotlandi) - The role of IGF2BP3 in the interaction between Ewing Sarcoma cells and the immune cell microenvironment
FERACO PAOLA (Sup. Prof. A. G. Morganti) - Radiogenomic study of glial tumors: non-invasive identification of specific diagnostic markers of idh mutation status and KI67 expression
GRILLI GIADA (Sup. Prof. Andrea Ardizzoni) - Molecular target therapy and immunotherapy of rare lung tumors
ROCCHI SERENA (Sup. Prof. Michele Cavo) - Use of the monoclonal antibody Daratumumab combined with standard therapy for patients with newly diagnosed multiple myeloma eligible for high-dose chemotherapy in a multicenter phase II clinical protocol
SAMBRI ANDREA (Sup. Dr. Gabriele Donati) - Molecular profiling of myxofibrosarcoma of the extremities: diagnostic and prognostic impact
SARTOR CHIARA (Sup. Prof. Michele Cavo) - Mechanisms of resistance to Inotuzumab Ozagamicin immunotherapy in patients with acute lymphoblastic leukemia
SCHIPANI ANGELA (Sup. Prof.ssa Maria Pantaleo) - Comprehensive characterization of SDH-deficient GIST using NGS data and IPS models
SESSA MARIA ROSARIA (Sup. Prof. Michele Cavo) - Methyloma in allogeneic hematopoietic stem cell transplantation
SETOLA ELISABETTA (Sup. Prof.ssa Maria Pantaleo) - Microenvironment and prognostic factors in bone sarcomas